Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.
about
Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivoSecond sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusionOncolytic Sendai virus-based virotherapy for cancer: recent advancesRefolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy.Wheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibodyN-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbillivirusesProbing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies.Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes.Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusionDiscovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencingFusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperature-dependent defect in receptor bindingMutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase proteinEnhanced sialic acid-dependent endocytosis explains the increased efficiency of infection of airway epithelia by a novel adeno-associated virusRole of the two sialic acid binding sites on the newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusionPhosphorylation of Nonmuscle myosin II-A regulatory light chain resists Sendai virus fusion with host cells.Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein.Ephrin-B2 and ephrin-B3 as functional henipavirus receptorsParamyxovirus fusion and entry: multiple paths to a common endProteomic analysis of purified Newcastle disease virus particles.A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusionNew insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2Interacting domains of the HN and F proteins of newcastle disease virus.Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin-neuraminidase protein: implications for the mechanism of fusion promotion.Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingParamyxoviruses: different receptors - different mechanisms of fusion.Mutagenesis of Paramyxovirus Hemagglutinin-Neuraminidase Membrane-Proximal Stalk Region Influences Stability, Receptor Binding, and Neuraminidase Activity.Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein.Viral entry mechanisms: the increasing diversity of paramyxovirus entry.Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state.Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cellsMutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion.Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.Recent developments with live-attenuated recombinant paramyxovirus vaccines.RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent.Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.Presence of a full-length highly polymorphic region (HPR) in the ISAV haemagglutinin-esterase does not affect the primary functions of receptor binding and esterase activity.Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein.
P2860
Q24567591-89A440A3-06F2-4C37-90EF-B9D534504551Q24600140-3D638054-242C-4980-AD3F-0872B9BB8402Q26825239-495BEA38-E238-406A-9D7D-9D2F105E0436Q33263085-5FCE79CF-E53D-4D2A-93AA-7E7D0363805EQ33633800-EE9CFE2F-A203-40E3-A7A0-E5A0506221F3Q33676467-E6219C3B-7F26-407D-9C9A-972495E61E21Q33820699-13192EF6-CADF-42A6-BC53-FD4214D87936Q34261586-07E26DEB-EB69-4C06-A052-C3F3B0BA3C34Q34434940-82CE3F3F-4276-4002-BA3C-F8C02916F3A1Q34745220-60991223-04DC-4593-8E0E-2FCEABC7CD5FQ34977778-E5724C0B-112A-4150-8CD1-B00318254AE3Q35020586-2FFBC3AB-B8B6-41B9-93F4-BE7A83D1585DQ35024321-98131F62-DCD6-4FC7-B1A3-EB85A9F29D56Q35192893-6F74E078-1356-4EB2-A1AF-D4901B814CDAQ35531376-67266C01-D456-4F21-A656-E9931B8745EFQ35627423-CDFB1F04-8E38-4760-ACF4-15E369BBF62AQ35664943-75DAF2F8-2363-4191-9F9C-D97B03CD15DAQ35785110-A30DF42A-701C-429C-B218-549C1A51FCB8Q35892085-4EAB247C-212D-4529-8307-6D95FEA8EB34Q35943669-7830A09E-3CB4-4E1C-AA7F-322EB5EF5026Q36146280-A15DC1BD-54AA-4FD0-8ED9-0DEF0B6B12D1Q36324552-990CE36A-30AC-49AA-A6C3-7F05C5D66404Q36373573-3E94BBB2-01AF-413C-9CF1-F6A7A1439FBBQ36474158-1B877756-A1A9-4268-ABC6-98F93CCF856DQ36949597-CC77872B-DE8F-4E14-833B-FD83F75C0B96Q36949836-6FA262B2-C3D4-48DA-90C9-2BE6E3F73D2CQ37019201-7CE44F38-ECEE-40BB-B0D7-B8751BE548A3Q37182636-7E6032BE-2CBC-49C9-8464-C9E0E504E00BQ37596521-69ED48A8-E1AD-4DB6-85BB-B80F2CF57487Q37624858-F91F4A04-A0A9-416F-BDB2-AAC20D42A4F9Q37683548-B36F51F8-2811-40C9-BC81-FB59CC2ABE94Q37713834-1BA02C56-94C6-4835-B68C-A119C56AF3F4Q37730455-9C6A9446-DBE9-40D9-818D-9CE81B8F11ABQ37743793-04066870-3169-4CDC-B382-33B0737CA2D3Q38008607-02F77FFB-E7B7-42F0-9A55-A373519CBEB0Q38121503-294D429D-5DB5-455E-BC2F-5E0D13C3B4FEQ38355328-93F94102-E90B-4ADA-826F-53865CA73599Q38700909-CB032849-7AEC-4D51-8D20-06C4C8F609B8Q39116054-DC0CB860-25E1-4917-8BD4-A33D4F02F8C7Q39142106-9CBDCD82-1E2C-4075-AF9E-2FC850846CCD
P2860
Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of the hemagglutinin-neur ...... myxovirus-cell membrane fusion
@nl
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@ast
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@en
type
label
Role of the hemagglutinin-neur ...... myxovirus-cell membrane fusion
@nl
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@ast
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@en
prefLabel
Role of the hemagglutinin-neur ...... myxovirus-cell membrane fusion
@nl
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@ast
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@en
P2093
P2860
P1433
P1476
Role of the hemagglutinin-neur ...... yxovirus-cell membrane fusion.
@en
P2093
Allen Portner
Garry L Taylor
Helen C Connaris
Susan J Crennell
Toru Takimoto
P2860
P304
13028-13033
P356
10.1128/JVI.76.24.13028-13033.2002
P407
P577
2002-12-01T00:00:00Z